Mimedx (MDXG) Interest Expenses (2010 - 2026)

Mimedx (MDXG) has 17 years of Interest Expenses data on file, last reported at $402000.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 34.31% year-over-year to $402000.0; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 358.99% YoY), and the FY2025 full-year result was $11.1 million, up 181.44% from the prior year.
• Interest Expenses retreated to $402000.0 in Q1 2026, from $712000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2.4 million in Q1 2024 to a low of -$2.9 million in Q4 2023.
• A 5-year average of $893764.7 and a median of $1.1 million in 2022 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses sank 257.63% in 2023 and surged 204.86% in 2025, its largest moves.
• Tracing MDXG's Interest Expenses over 5 years: stood at $1.8 million in 2022, then slumped by 257.63% to -$2.9 million in 2023, then jumped by 76.27% to -$679000.0 in 2024, then surged by 204.86% to $712000.0 in 2025, then plunged by 43.54% to $402000.0 in 2026.
• Business Quant data shows MDXG's Interest Expenses at $402000.0 in Q1 2026, $712000.0 in Q4 2025, and $731000.0 in Q3 2025.